Literature DB >> 16864761

Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings.

Benjamin J Cowling1, Matthew P Muller, Irene O L Wong, Lai-Ming Ho, Su-Vui Lo, Thomas Tsang, Tai Hing Lam, Marie Louie, Gabriel M Leung.   

Abstract

BACKGROUND: An accurate prognostic model for patients with severe acute respiratory syndrome (SARS) could provide a practical clinical decision aid. We developed and validated prognostic rules for both high- and low-resource settings based on data available at the time of admission.
METHODS: We analyzed data on all 1755 and 291 patients with SARS in Hong Kong (derivation cohort) and Toronto (validation cohort), respectively, using a multivariable logistic scoring method with internal and external validation. Scores were assigned on the basis of patient history in a basic model, and a full model additionally incorporated radiological and laboratory results. The main outcome measure was death.
RESULTS: Predictors for mortality in the basic model included older age, male sex, and the presence of comorbid conditions. Additional predictors in the full model included haziness or infiltrates on chest radiography, less than 95% oxygen saturation on room air, high lactate dehydrogenase level, and high neutrophil and low platelet counts. The basic model had an area under the receiver operating characteristic (ROC) curve of 0.860 in the derivation cohort, which was maintained on external validation with an area under the ROC curve of 0.882. The full model improved discrimination with areas under the ROC curve of 0.877 and 0.892 in the derivation and validation cohorts, respectively.
CONCLUSION: The model performs well and could be useful in assessing prognosis for patients who are infected with re-emergent SARS.

Entities:  

Mesh:

Year:  2006        PMID: 16864761     DOI: 10.1001/archinte.166.14.1505

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan.

Authors:  Eric H Y Lau; C Agnes Hsiung; Benjamin J Cowling; Chang-Hsun Chen; Lai-Ming Ho; Thomas Tsang; Chiu-Wen Chang; Christl A Donnelly; Gabriel M Leung
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

2.  Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.

Authors:  Mark J Cameron; Longsi Ran; Luoling Xu; Ali Danesh; Jesus F Bermejo-Martin; Cheryl M Cameron; Matthew P Muller; Wayne L Gold; Susan E Richardson; Susan M Poutanen; Barbara M Willey; Mark E DeVries; Yuan Fang; Charit Seneviratne; Steven E Bosinger; Desmond Persad; Peter Wilkinson; Larry D Greller; Roland Somogyi; Atul Humar; Shaf Keshavjee; Marie Louie; Mark B Loeb; James Brunton; Allison J McGeer; David J Kelvin
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

3.  Clinical imaging characteristics of inpatients with coronavirus disease-2019 in Heilongjiang Province, China: a retrospective study.

Authors:  Hao Jiang; Wei Guo; Zhongxing Shi; Huijie Jiang; Mingyu Zhang; Lai Wei; Yongmei Pan
Journal:  Aging (Albany NY)       Date:  2020-07-20       Impact factor: 5.682

4.  Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020.

Authors:  Peng Wu; Xinxin Hao; Eric H Y Lau; Jessica Y Wong; Kathy S M Leung; Joseph T Wu; Benjamin J Cowling; Gabriel M Leung
Journal:  Euro Surveill       Date:  2020-01

5.  Reductions of migrant population reduces the number of COVID-19 epidemic: a case study in China.

Authors:  Lizhen Han; Jinzhu Jia
Journal:  Environ Sci Pollut Res Int       Date:  2021-06-11       Impact factor: 5.190

6.  Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.

Authors:  Eric H Y Lau; Benjamin J Cowling; Matthew P Muller; Lai-Ming Ho; Thomas Tsang; Su-Vui Lo; Marie Louie; Gabriel M Leung
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

Review 7.  Advances in the relationship between coronavirus infection and cardiovascular diseases.

Authors:  Mengmeng Zhao; Menglong Wang; Jishou Zhang; Jing Ye; Yao Xu; Zhen Wang; Di Ye; Jianfang Liu; Jun Wan
Journal:  Biomed Pharmacother       Date:  2020-05-13       Impact factor: 7.419

Review 8.  COVID-19: what has been learned and to be learned about the novel coronavirus disease.

Authors:  Ye Yi; Philip N P Lagniton; Sen Ye; Enqin Li; Ren-He Xu
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.